Cybersecurity News that Matters

Cybersecurity News that Matters

BigBear.ai Announces Second Quarter 2025 Results; Updates Financial Outlook

Default Image of Readable

by Business Wire

Aug. 12, 2025
5:35 AM GMT+9
  • Sequential improvement to the balance sheet and record cash balance of $390.8 million, as of June 30, 2025, positioning the Company to accelerate growth.
  • Company now projects full-year 2025 revenue between $125 million and $140 million.

MCLEAN, Va.–(BUSINESS WIRE)–BigBear.ai Holdings, Inc. (NYSE: BBAI) (“BigBear.ai” or the “Company”), a leader in AI-powered decision intelligence solutions, today announced financial results for the second quarter of 2025 and issued an investor presentation that has been posted to the Investor Relations section of the Company’s website.


“Our robust balance sheet allows us to make significant transformational investments to shape the future of BigBear.ai. Our capital raising activities this quarter coincide with the tremendous opportunities we see coming from the One Big Beautiful Bill, particularly in the Department of Homeland Security, and several of which are uniquely aligned to our core capabilities. This legislation will bring a generational investment and provides over $170 billion in supplemental funding to the Department of Homeland Security, and $150 billion to the Department of Defense for disruptive defense technology. This is not incremental funding for innovation – this is a transformative level of investment. As a Mission Ready AI company with a national and border security focus, it’s directly in our lane,” said Kevin McAleenan, CEO of BigBear.ai.

“Beyond the opportunities that we’re pursuing in the U.S., this quarter, we signed a transformative partnership with leading companies in the UAE under the IHC umbrella focused on accelerating the development and adoption of AI across several domains and applications. This is just the beginning of our international expansion and demonstrates the need for BigBear.ai’s technology and solutions across the globe,” he continued.

“While we are very optimistic with these significant investments and growth opportunities, we have also seen disruptions in federal contracts from efficiency efforts this quarter, most notably in programs that support the U.S. Army, as they seek to consolidate and modernize their data architecture and in turn, we have adjusted our full-year guidance this quarter to reflect these disruptions,” he concluded.

“Our record cash balance will enable us to make significant investments, both organically and inorganically, in an order of magnitude that was not possible before,” said Sean Ricker, CFO of BigBear.ai.

Financial Highlights

  • Revenue decreased 18% to $32.5 million for the second quarter of 2025, compared to $39.8 million for the second quarter of 2024 primarily due to lower volume on certain Army programs.
  • Gross margin was 25.0% in the second quarter of 2025, compared to 27.8% in the second quarter of 2024.
  • Net loss in the second quarter of 2025 was $228.6 million, compared to a net loss of $14.4 million for the second quarter of 2024. The increase in net loss was primarily driven by non-cash changes in derivative liabilities of $135.8 million associated with changes in the fair value of the convertible features of the 2029 Notes and warrants, as well as a non-cash goodwill impairment charge of $70.6 million.
  • Non-GAAP Adjusted EBITDA* of $(8.5) million for the second quarter of 2025 compared to $(3.7) million for the second quarter of 2024, primarily driven by decreased gross margin as well as an increase in research and development expenses.
  • SG&A of $21.5 million for the second quarter of 2025 compared to $23.4 million for the second quarter of 2024. The year-over-year decrease was primarily driven by lower legal expenses ($1.7 million), and lower bonus expense ($1.1 million).
  • Backlog of $380 million as of June 30, 2025.

Financial Outlook

For the year-ended December 31, 2025, the Company now projects:

  • Revenue between $125 million and $140 million

Due to uncertainty on certain Army programs as well as new anticipated growth investment spending in the second half of the year, at this time, the Company is withdrawing its previously provided Adjusted EBITDA guidance for the year-ended December 31, 2025. The Company expects to provide updated Adjusted EBITDA guidance at a later date. The above information on financial outlook, and other sections of this release contain forward-looking statements, which are based on the Company’s current expectations. Actual results may differ materially from those projected. It is the Company’s practice not to incorporate adjustments into its financial outlook for proposed acquisitions, divestitures, changes in law, or new accounting standards until such items have been consummated, enacted, or adopted, as the case may be. For additional factors that may impact the Company’s actual results, refer to the “Forward-Looking Statements” section in this release.

*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section in this press release for additional information and reconciliations.

Summary of Results for the Second Quarter Ended

June 30, 2025 and June 30, 2024

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended
June 30,

$ thousands (expect per share amounts)

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenues

$

32,472

 

 

$

39,783

 

 

$

67,229

 

 

$

72,904

 

Cost of revenues

 

24,359

 

 

 

28,720

 

 

 

51,728

 

 

 

54,855

 

Gross margin

 

8,113

 

 

 

11,063

 

 

 

15,501

 

 

 

18,049

 

Operating expenses:

 

 

 

 

 

 

 

Selling, general and administrative

 

21,487

 

 

 

23,364

 

 

 

44,219

 

 

 

40,312

 

Research and development

 

4,393

 

 

 

3,565

 

 

 

8,559

 

 

 

4,709

 

Restructuring charges

 

1,899

 

 

 

457

 

 

 

3,597

 

 

 

1,317

 

Transaction expenses

 

 

 

 

347

 

 

 

 

 

 

1,450

 

Goodwill impairment

 

70,636

 

 

 

 

 

 

70,636

 

 

 

85,000

 

Operating loss

 

(90,302

)

 

 

(16,670

)

 

 

(111,510

)

 

 

(114,739

)

Interest expense

 

4,419

 

 

 

6,452

 

 

 

9,535

 

 

 

12,837

 

Net increase (decrease) in fair value of derivatives

 

135,751

 

 

 

(8,081

)

 

 

169,087

 

 

 

15,726

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

2,577

 

 

 

 

Other income, net

 

(1,867

)

 

 

(617

)

 

 

(2,143

)

 

 

(1,072

)

Loss before taxes

 

(228,605

)

 

 

(14,424

)

 

 

(290,566

)

 

 

(142,230

)

Income tax expense

 

14

 

 

 

15

 

 

 

39

 

 

 

1

 

Net loss

$

(228,619

)

 

$

(14,439

)

 

$

(290,605

)

 

$

(142,231

)

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

(0.71

)

 

$

(0.06

)

 

$

(0.97

)

 

$

(0.66

)

 

 

 

 

 

 

 

 

Weighted-average shares outstanding:

 

 

 

 

 

 

 

Basic

 

320,591,204

 

 

 

246,303,139

 

 

 

299,666,133

 

 

 

216,754,082

 

Diluted

 

320,591,204

 

 

 

246,303,139

 

 

 

299,666,133

 

 

 

216,754,082

 

 

Consolidated Balance Sheets as of

June 30, 2025 and December 31, 2024

(Unaudited)

 

 

 

 

$ in thousands (except per share amounts)

June 30,
2025

 

December 31,

2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

390,845

 

 

$

50,141

 

Accounts receivable, less allowance for credit losses

 

28,342

 

 

 

38,953

 

Contract assets

 

701

 

 

 

895

 

Prepaid expenses and other current assets

 

4,395

 

 

 

3,768

 

Total current assets

 

424,283

 

 

 

93,757

 

Non-current assets:

 

 

 

Property and equipment, net

 

1,425

 

 

 

1,566

 

Goodwill

 

48,446

 

 

 

119,081

 

Intangible assets, net

 

115,621

 

 

 

119,119

 

Right-of-use assets

 

8,639

 

 

 

9,263

 

Other non-current assets

 

958

 

 

 

990

 

Total assets

$

599,372

 

 

$

343,776

 

 

 

 

 

Liabilities and stockholders’ equity (deficit)

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

3,440

 

 

$

8,455

 

Short-term debt, including current portion of long-term debt

 

367

 

 

 

818

 

Accrued liabilities

 

16,555

 

 

 

19,496

 

Contract liabilities

 

4,466

 

 

 

2,541

 

Current portion of long-term lease liability

 

1,096

 

 

 

1,068

 

Derivative liabilities

 

193,199

 

 

 

170,515

 

Other current liabilities

 

2,522

 

 

 

73

 

Total current liabilities

 

221,645

 

 

 

202,966

 

Non-current liabilities:

 

 

 

Long-term debt, net

 

102,683

 

 

 

135,404

 

Long-term lease liability

 

8,494

 

 

 

9,120

 

Total liabilities

 

332,822

 

 

 

347,490

 

Stockholders’ equity (deficit)

 

 

 

Common stock, par value $0.0001; 500,000,000 shares authorized and 369,171,608 shares issued and outstanding at June 30, 2025 and 251,554,378 shares issued and outstanding at December 31, 2024

 

39

 

 

 

26

 

Additional paid-in capital

 

1,186,256

 

 

 

625,130

 

Treasury stock, at cost 9,952,803 shares at June 30, 2025 and December 31, 2024

 

(57,350

)

 

 

(57,350

)

Accumulated deficit

 

(862,246

)

 

 

(571,641

)

Accumulated other comprehensive (loss) income

 

(149

)

 

 

121

 

Total stockholders’ equity (deficit)

 

266,550

 

 

 

(3,714

)

Total liabilities and stockholders’ equity (deficit)

$

599,372

 

 

$

343,776

 

 

Consolidated Statements of Cash Flows for the Six Months Ended

June 30, 2025 and June 30, 2024

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

$ in thousands

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net loss

$

(228,619

)

 

$

(14,439

)

 

$

(290,605

)

 

$

(142,231

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization expense

 

3,451

 

 

 

2,907

 

 

 

6,921

 

 

 

5,346

 

Amortization of debt issuance costs and discount

 

2,026

 

 

 

3,407

 

 

 

4,790

 

 

 

6,743

 

Equity-based compensation expense

 

4,319

 

 

 

5,749

 

 

 

11,719

 

 

 

10,906

 

Goodwill impairment

 

70,636

 

 

 

 

 

 

70,636

 

 

 

85,000

 

Non-cash lease expense

 

254

 

 

 

269

 

 

 

624

 

 

 

363

 

Provision for doubtful accounts

 

311

 

 

 

5

 

 

 

351

 

 

 

176

 

Deferred income tax benefit

 

 

 

 

(14

)

 

 

 

 

 

(37

)

Loss on extinguishment of debt

 

 

 

 

 

 

 

2,577

 

 

 

 

Net increase (decrease) in fair value of derivatives

 

135,751

 

 

 

(8,081

)

 

 

169,087

 

 

 

15,726

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

Decrease (increase) in accounts receivable

 

5,919

 

 

 

2,725

 

 

 

10,267

 

 

 

(6,232

)

(Increase) decrease in contract assets

 

(189

)

 

 

1,338

 

 

 

194

 

 

 

3,781

 

Decrease (increase) in prepaid expenses and other assets

 

1,203

 

 

 

293

 

 

 

(592

)

 

 

1,243

 

(Decrease) increase in accounts payable

 

(876

)

 

 

913

 

 

 

(5,039

)

 

 

(5,047

)

Increase (decrease) in accrued expenses

 

319

 

 

 

(947

)

 

 

4,765

 

 

 

1,652

 

Increase (decrease) in contract liabilities

 

1,449

 

 

 

(357

)

 

 

1,925

 

 

 

1,469

 

Increase (decrease) in other liabilities

 

178

 

 

 

(826

)

 

 

1,848

 

 

 

(275

)

Net cash used in operating activities

 

(3,868

)

 

 

(7,058

)

 

 

(10,532

)

 

 

(21,417

)

Cash flows from investing activities:

 

 

 

 

 

 

 

Acquisition of business, net of cash acquired

 

 

 

 

 

 

 

 

 

 

13,935

 

Purchases of property and equipment

 

(5

)

 

 

(129

)

 

 

(85

)

 

 

(167

)

Capitalized software development costs

 

(1,159

)

 

 

(1,582

)

 

 

(2,699

)

 

 

(3,225

)

Net cash (used in) provided by investing activities

 

(1,164

)

 

 

(1,711

)

 

 

(2,784

)

 

 

10,543

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Proceeds from issuance of shares for exercised RDO and PIPE warrants

 

 

 

 

 

 

 

64,673

 

 

 

53,809

 

Payment of RDO and PIPE transaction costs

 

 

 

 

 

 

 

(551

)

 

 

 

Proceeds from at-the-market offering

 

293,431

 

 

 

 

 

 

300,000

 

 

 

 

Payment of transaction costs for at-the-market offering

 

(5,135

)

 

 

 

 

 

(5,250

)

 

 

 

Repayment of short-term borrowings

 

(85

)

 

 

(409

)

 

 

(451

)

 

 

(812

)

Payment of debt issuance costs to third parties

 

(337

)

 

 

 

 

 

(4,679

)

 

 

 

Proceeds from exercise of options

 

240

 

 

 

33

 

 

 

1,633

 

 

 

119

 

Issuance of common stock upon ESPP purchase

 

1,069

 

 

 

607

 

 

 

1,069

 

 

 

607

 

Payments of tax withholding from the issuance of common stock

 

(361

)

 

 

(608

)

 

 

(1,679

)

 

 

(3,140

)

Net cash provided by (used in) financing activities

 

288,822

 

 

 

(377

)

 

 

354,765

 

 

 

50,583

 

Effect of foreign currency rate changes on cash and cash equivalents

 

(555

)

 

 

 

 

 

(745

)

 

 

 

Net increase (decrease) in cash and cash equivalents

 

283,235

 

 

 

(9,146

)

 

 

340,704

 

 

 

39,709

 

Cash and cash equivalents at the beginning of period

 

107,610

 

 

 

81,412

 

 

 

50,141

 

 

 

32,557

 

Cash and cash equivalents at the end of the period

$

390,845

 

 

$

72,266

 

 

$

390,845

 

 

$

72,266

 

 

EBITDA* and Adjusted EBITDA* for the Second Quarter Ended

June 30, 2025 and June 30, 2024

(Unaudited)

 

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

$ thousands

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net loss

$

(228,619

)

 

$

(14,439

)

 

$

(290,605

)

 

$

(142,231

)

Interest expense

 

4,419

 

 

 

6,452

 

 

 

9,535

 

 

 

12,837

 

Interest income

 

(1,704

)

 

 

(725

)

 

 

(2,260

)

 

 

(1,172

)

Income tax expense

 

14

 

 

 

15

 

 

 

39

 

 

 

1

 

Depreciation and amortization

 

3,451

 

 

 

2,907

 

 

 

6,921

 

 

 

5,346

 

EBITDA

 

(222,439

)

 

 

(5,790

)

 

 

(276,370

)

 

 

(125,219

)

Adjustments:

 

 

 

 

 

 

 

Equity-based compensation

 

4,319

 

 

 

5,749

 

 

 

11,719

 

 

 

10,906

 

Employer payroll taxes related to equity-based compensation(1)

 

611

 

 

 

48

 

 

 

1,626

 

 

 

712

 

Loss on extinguishment of debt(9)

 

 

 

 

 

 

 

2,577

 

 

 

 

Net increase (decrease) in fair value of derivatives(2)

 

135,751

 

 

 

(8,081

)

 

 

169,087

 

 

 

15,726

 

Restructuring charges(3)

 

1,899

 

 

 

457

 

 

 

3,597

 

 

 

1,317

 

Non-recurring strategic initiatives(4)

 

717

 

 

 

2,040

 

 

 

1,611

 

 

 

3,374

 

Non-recurring litigation(5)

 

8

 

 

 

666

 

 

 

30

 

 

 

545

 

Transaction expenses(6)

 

 

 

 

347

 

 

 

 

 

 

1,450

 

Non-recurring integration costs(7)

 

 

 

 

883

 

 

 

 

 

 

883

 

Goodwill impairment(8)

 

70,636

 

 

 

 

 

 

70,636

 

 

 

85,000

 

Adjusted EBITDA

$

(8,498

)

 

$

(3,681

)

 

$

(15,487

)

 

$

(5,306

)

(1)

Includes employer payroll taxes due upon the vesting of equity awards granted to employees.

(2)

The change in fair value of derivatives during the three months ended June 30, 2025 relates to the remeasurement of the 2025 warrants, IPO warrants and the 2026 and 2029 Notes Conversion Options derivative liabilities. The change during the six months ended June 30, 2025, relates to the $14.0 million loss recorded upon the exercise of the 2024 RDO and 2024 PIPE Warrants (the “2024 Warrants”) and issuance of the warrants in 2025 (the “2025 Warrants”) in connection with the warrant exercise agreements entered into on February 5, 2025. During the six months ended June 30, 2025, there was loss related to a mark-to-market adjustment of $59.9M adjustment for the debt to equity conversions during the period. There was an offsetting gain related to the fair market value adjustment on the 2025 warrants and the private warrants of $2.6 million. Additionally, there was an loss of $7.0 million fair market value adjustment of the 2026 and 2029 Notes Conversion Option, during the six months ended June 30, 2025.

 

The decrease in fair value of derivatives during the three months ended June 30, 2024 relates to remeasurement of the 2024 Warrants and IPO Warrant’s fair value. The increase in fair value of derivatives during the six months ended June 30, 2024, relates to the $42.3 million loss recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants (the “2023 Warrants”) in connection with the warrant exercise agreements entered into on February 27, 2024 and March 4, 2024. This loss was offset by gains of $10.6 million, net of cash proceeds received, related to the issuance of warrants in 2024 (the “2024 Warrants”). In addition, an $18.3 million reduction in fair value was recorded on the 2024 Warrants issued in connection with the warrant exercise agreements as the fair value decreased from the issue date to quarter end.

(3)

During the three and six months ended June 30, 2025 and June 30, 2024, the Company incurred employee separation costs associated with a strategic review of the Company’s capacity and future projections to better align the organization and cost structure and improve the affordability of its products and services.

(4)

Non-recurring professional fees related to the execution of certain strategic initiatives of the Company.

(5)

Non-recurring litigation consists primarily of legal settlements and related fees for specific proceedings that we have determined arise outside of the ordinary course of business based on the following considerations which we assess regularly: (1) the frequency of similar cases that have been brought to date, or are expected to be brought within two years; (2) the complexity of the case; (3) the nature of the remedy(ies) sought, including the size of any monetary damages sought; (4) offensive versus defensive posture of us; (5) the counterparty involved; and (6) our overall litigation strategy.

(6)

Transaction expenses during the quarter ended March 31, 2024 consist primarily of diligence, legal and other related expenses incurred associated with the Pangiam acquisition.

(7)

Non-recurring internal integration costs related to the Pangiam acquisition.

(8)

During the three months ended March 31, 2024, the Company recognized a non-cash goodwill impairment charge primarily driven by a decrease in share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam. During the six months ended June 30, 2025, the company recognized a non-cash goodwill impairment charge of $70.6 million, primarily driven by a change in forecast during the second quarter of 2025.

(9)

Loss on extinguishment of debt is related to voluntary conversions of the 2029 Notes to common stock and the related extinguishment of unamortized debt discount and debt costs.

 

*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section in this press release for additional information and reconciliations.

Adjusted EBITDA* Reconciliation for the Second Quarter Ended

June 30, 2025 and June 30, 2024

(Unaudited)

 

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

$ in thousands

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenue

$

32,472

 

 

$

39,783

 

 

$

67,229

 

 

$

72,904

 

Net loss

 

(228,619

)

 

 

(14,439

)

 

 

(290,605

)

 

 

(142,231

)

Interest expense

 

4,419

 

 

 

6,452

 

 

 

9,535

 

 

 

12,837

 

Interest income

 

(1,704

)

 

 

(725

)

 

 

(2,260

)

 

 

(1,172

)

Income tax expense

 

14

 

 

 

15

 

 

 

39

 

 

 

1

 

Depreciation and amortization

 

3,451

 

 

 

2,907

 

 

 

6,921

 

 

 

5,346

 

EBITDA*

$

(222,439

)

 

$

(5,790

)

 

$

(276,370

)

 

$

(125,219

)

Adjustments:

 

 

 

 

 

 

 

Equity-based compensation

 

4,319

 

 

 

5,749

 

 

 

11,719

 

 

 

10,906

 

Employer payroll taxes related to equity-based compensation(1)

 

611

 

 

 

48

 

 

 

1,626

 

 

 

712

 

Net increase in fair value of derivatives(2)

 

135,751

 

 

 

(8,081

)

 

 

169,087

 

 

 

15,726

 

Restructuring charges(3)

 

1,899

 

 

 

457

 

 

 

3,597

 

 

 

1,317

 

Non-recurring strategic initiatives(4)

 

717

 

 

 

2,040

 

 

 

1,611

 

 

 

3,374

 

Non-recurring litigation(5)

 

8

 

 

 

666

 

 

 

30

 

 

 

545

 

Transaction expenses(6)

 

 

 

 

347

 

 

 

 

 

 

1,450

 

Non-recurring integration costs(7)

 

 

 

 

883

 

 

 

 

 

 

883

 

Goodwill impairment(8)

 

70,636

 

 

 

 

 

 

70,636

 

 

 

85,000

 

Loss on extinguishment of debt(9)

 

 

 

 

 

 

 

2,577

 

 

 

 

Adjusted EBITDA*

$

(8,498

)

 

$

(3,681

)

 

$

(18,064

)

 

$

(5,306

)

Gross Margin

 

25.0

%

 

 

27.8

%

 

 

23.1

%

 

 

24.8

%

Net Loss Margin

 

(704.0

)%

 

 

(36.3

)%

 

 

(432.3

)%

 

 

(195.1

)%

Adjusted EBITDA* Margin

 

(26.2

)%

 

 

(9.3

)%

 

 

(26.9

)%

 

 

(7.3

)%

(1)

Includes employer payroll taxes due upon the vesting of equity awards granted to employees.

(2)

The change in fair value of derivatives during the three months ended June 30, 2025 relates to the remeasurement of the 2025 warrants, IPO warrants and the 2026 and 2029 Notes Conversion Options derivative liabilities. The change during the six months ended June 30, 2025, relates to the $14.0 million loss recorded upon the exercise of the 2024 RDO and 2024 PIPE Warrants (the “2024 Warrants”) and issuance of the warrants in 2025 (the “2025 Warrants”) in connection with the warrant exercise agreements entered into on February 5, 2025. During the six months ended June 30, 2025, there was loss related to a mark-to-market adjustment of $59.9M adjustment for the debt to equity conversions during the period. There was an offsetting gain related to the fair market value adjustment on the 2025 warrants and the private warrants of $2.6 million. Additionally, there was an loss of $7.0 million fair market value adjustment of the 2026 and 2029 Notes Conversion Option, during the six months ended June 30, 2025.

 

The decrease in fair value of derivatives during the three months ended June 30, 2024 relates to remeasurement of the 2024 Warrants and IPO Warrant’s fair value. The increase in fair value of derivatives during the six months ended June 30, 2024, relates to the $42.3 million loss recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants (the “2023 Warrants”) in connection with the warrant exercise agreements entered into on February 27, 2024 and March 4, 2024. This loss was offset by gains of $10.6 million, net of cash proceeds received, related to the issuance of warrants in 2024 (the “2024 Warrants”). In addition, an $18.3 million reduction in fair value was recorded on the 2024 Warrants issued in connection with the warrant exercise agreements as the fair value decreased from the issue date to quarter end.

(3)

During the three and six months ended June 30, 2025 and June 30, 2024, the Company incurred employee separation costs associated with a strategic review of the Company’s capacity and future projections to better align the organization and cost structure and improve the affordability of its products and services.

(4)

Non-recurring professional fees related to the execution of certain strategic initiatives of the Company.

(5)

Non-recurring litigation consists primarily of legal settlements and related fees for specific proceedings that we have determined arise outside of the ordinary course of business based on the following considerations which we assess regularly: (1) the frequency of similar cases that have been brought to date, or are expected to be brought within two years; (2) the complexity of the case; (3) the nature of the remedy(ies) sought, including the size of any monetary damages sought; (4) offensive versus defensive posture of us; (5) the counterparty involved; and (6) our overall litigation strategy.

(6)

Transaction expenses during the quarter ended March 31, 2024 consist primarily of diligence, legal and other related expenses incurred associated with the Pangiam acquisition.

(7)

Non-recurring internal integration costs related to the Pangiam acquisition.

(8)

During the three months ended March 31, 2024, the Company recognized a non-cash goodwill impairment charge primarily driven by a decrease in share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam. During the six months ended June 30, 2025, the company recognized a non-cash goodwill impairment charge of $70.6 million, primarily driven by a change in forecast during the second quarter of 2025.

(9)

Loss on extinguishment of debt is related to voluntary conversions of the 2029 Notes to common stock and the related extinguishment of unamortized debt discount and debt costs.

 

*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section in this press release for additional information and reconciliations.

Forward-Looking Statements

This release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933 (the “Securities Act”), the Securities Exchange Act of 1934 (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our industry, future events, and other statements that are not historical facts.

Contacts

BigBear.ai

[email protected]

Media Contact
[email protected]

Read full story here

Subscription

Subscribe to our newsletter for the latest insights and trends. Tailor your subscription to fit your interests:

By subscribing, you agree to our Privacy Policy. We respect your privacy and are committed to protecting your personal data. Your email address will only be used to send you the information you have requested, and you can unsubscribe at any time through the link provided in our emails.

  • Business Wire

    Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Public relations, investor relations, public policy and marketing profession...

    View all posts
Author:
Stay Ahead with The Readable's Cybersecurity Insights